tiprankstipranks
Trending News
More News >
Biosyent Inc (TSE:RX)
:RX
Canadian Market

Biosyent (RX) Revenue

Compare
45 Followers

Biosyent Revenue

Biosyent had a revenue of 9.56M in the quarter ending Sep 30, 2024, with 6.84%. This bring the company's revenue in the last twelve months to 34.51M, Decreased 2.02%. In the fiscal year ending Dec 31, 2023, Biosyent had annual revenue of 31.59M with 13.12% growth.
Revenue (ttm)
34.51M
Revenue Growth
16.55%
P/S Ratio
3.90
Revenue/Employee
Employees
Market Cap
C$123.31M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
31.59M3.67M+13.12%
Dec 31, 2022
27.93M-693.03K-2.42%
Dec 31, 2021
28.62M6.29M+28.15%
Dec 31, 2020
22.33M907.84K+4.24%
Dec 31, 2019
21.42M-102.70K-0.48%
Dec 31, 2018
21.53M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis